More than a third of older men with lower urinary tract symptoms (LUTS) derived little or no benefit from an alpha-blocker ...
Is there a safer, simpler alternative to epidural analgesia for patients recovering from femur fracture surgery? As ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
ScienceAlert on MSN
Non-Surgical Procedure Halves Knee Pain Over 12-Month Trial
(Quantic69/iStock/Getty Images Plus) Osteoarthritis in the knees can be very painful and very hard to treat. It often occurs ...
This first-in-class differentiated approach will be highlighted during a Featured Research Session entitled Alzheimer's therapy: mechanisms beyond amyloidROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE ...
Morning Overview on MSN
A new pancreatic-cancer drug nearly doubled survival and cut the risk of death by 60%
Patients with previously treated metastatic pancreatic cancer lived nearly twice as long when given daraxonrasib compared ...
Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy Immuron is seeking a partner to support ...
Levacetylleucine (Aqneursa) improved functioning in a phase III crossover trial of adults and children with ataxia-telangiectasia. Two patients had three treatment-emergent adverse events; none were ...
An electronics industry association report projected that the U.S. would surpass 100 million smart wearable users for the ...
One of the easiest and most effective ways to introduce this balance into daily structures is by utilizing specialized ...
Managing pain after lower limb orthopedic surgery is a daily challenge for anesthesiologists. While lumbar epidural analgesia ...
Tvardi Therapeutics (Nasdaq: TVRD) shares surge after Phase 1 results show TTI-109 matched TTI-101's exposure with better tolerability and clear STAT3 target engagement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results